The FCCA pharmacy market study proposes measures to reduce the costs of medicines for consumers and society* The Finnish Competition and Consumer Authority (FCCA) has published an extensive study on the pharmacy market. The study produced a list of proposals that can reduce the pharmaceutical costs for consumers and society and improve access to medicines. The profits generated by pharmacies for their owners have repeatedly been found to be relatively high, which is reflected in the pharmaceutical costs of consumers and society. Pharmacies operate in a growing market of approximately EUR 2.5 billion, which is heavily regulated. Pharmaceutical safety sets its own restrictions on how the sale of medicines can be organised. Nevertheless, customers and society could buy their medicines
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.